Cost-effectiveness of hydroxychloroquine retinopathy screening : the current guideline versus no screening and reduced regimens
Sara W. Quist, Sophie te Dorsthorst, Roel D. Freriks, Maarten J. Postma, Carel B. Hoyng, Freekje van Asten
| Year of publication: |
2025
|
|---|---|
| Authors: | Quist, Sara W. ; Dorsthorst, Sophie te ; Freriks, Roel D. ; Postma, Maarten J. ; Hoyng, Carel B. ; Asten, Freekje van |
| Published in: |
The European journal of health economics. - Berlin : Springer, ISSN 1618-7601, ZDB-ID 2011428-X. - Vol. 26.2025, 3, p. 413-425
|
| Subject: | Cost-effectiveness | Hydroxychloroquine retinopathy | Screening guidelines | Kosten-Wirksamkeits-Analyse | Cost-effectiveness analysis | Theorie | Theory | Signalling |
freely available
| Type of publication: | Article |
|---|---|
| Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
| Language: | English |
| Other identifiers: | 10.1007/s10198-024-01715-w [DOI] |
| Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10015394749